Sponsor:
Precision Biologics, Inc
Code:
NCT03476681
Conditions
Non Small Cell Lung Cancer
Head and Neck Squamous Cell Carcinoma
Cervical Cancer
Uterine Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NEO-201 in combination with pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-12. This information was provided to ClinicalTrials.gov by Precision Biologics, Inc on 2025-04-24.